Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Carrie Marshall

Concepts (147)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Thyroid Neoplasms
5
2024
380
1.010
Why?
Central Nervous System Neoplasms
1
2022
177
0.590
Why?
Cytological Techniques
1
2017
25
0.520
Why?
Observer Variation
2
2017
356
0.510
Why?
Endoscopic Ultrasound-Guided Fine Needle Aspiration
1
2017
62
0.500
Why?
Thyroid Nodule
3
2024
67
0.440
Why?
Biopsy, Fine-Needle
3
2019
79
0.390
Why?
Pathology, Molecular
1
2012
28
0.360
Why?
Mediastinum
1
2011
23
0.330
Why?
Lymphoproliferative Disorders
1
2011
59
0.320
Why?
Pancreatic Neoplasms
1
2017
944
0.290
Why?
Biomarkers, Tumor
5
2025
1339
0.270
Why?
Lymph Nodes
1
2011
511
0.270
Why?
Osteochondroma
1
2025
10
0.230
Why?
Nose Neoplasms
1
2025
22
0.230
Why?
Paranasal Sinus Neoplasms
1
2025
29
0.230
Why?
Hamartoma
1
2025
29
0.220
Why?
Thyroglobulin
1
2024
28
0.210
Why?
Diagnosis, Differential
5
2025
1503
0.200
Why?
Adamantinoma
1
2023
4
0.200
Why?
Thyroidectomy
1
2024
97
0.200
Why?
Carcinoma
2
2017
225
0.200
Why?
Carcinoma, Non-Small-Cell Lung
1
2012
1195
0.190
Why?
Gene Expression Regulation, Neoplastic
2
2021
1432
0.180
Why?
Bronchoscopy
2
2016
227
0.180
Why?
Tissue Scaffolds
1
2024
223
0.180
Why?
Paraneoplastic Syndromes
1
2021
14
0.180
Why?
Motor Neuron Disease
1
2021
21
0.170
Why?
Laboratories
2
2019
109
0.160
Why?
Surgical Wound Infection
1
2024
349
0.160
Why?
Bone Neoplasms
1
2023
272
0.160
Why?
Orthopedic Procedures
1
2023
260
0.160
Why?
Neoplasm Recurrence, Local
2
2024
1160
0.160
Why?
Pheochromocytoma
1
2021
67
0.160
Why?
Paraganglioma
1
2021
65
0.160
Why?
Extracellular Matrix
1
2024
565
0.150
Why?
Spine
1
2022
184
0.150
Why?
Proto-Oncogene Proteins B-raf
1
2022
231
0.150
Why?
Hodgkin Disease
1
2021
173
0.150
Why?
Carcinoma, Papillary
3
2017
83
0.150
Why?
Central Nervous System
1
2022
278
0.150
Why?
Neuroendocrine Tumors
1
2021
122
0.150
Why?
Pathology
1
2019
21
0.150
Why?
Pathology, Clinical
2
2017
29
0.150
Why?
Oncogene Proteins, Fusion
1
2021
213
0.140
Why?
Lung Neoplasms
1
2012
2675
0.140
Why?
Trans-Activators
1
2021
372
0.140
Why?
Mutation
3
2022
4093
0.140
Why?
Transcriptome
3
2021
1068
0.140
Why?
Smokers
1
2018
139
0.130
Why?
Radiotherapy, Intensity-Modulated
1
2018
143
0.130
Why?
Histocytochemistry
1
2017
77
0.120
Why?
Adenocarcinoma, Follicular
1
2017
43
0.120
Why?
Middle Aged
9
2024
36619
0.120
Why?
Cytodiagnosis
1
2016
31
0.120
Why?
Image-Guided Biopsy
1
2016
41
0.110
Why?
Optic Nerve
1
2016
65
0.110
Why?
Aged, 80 and over
4
2019
8391
0.110
Why?
Precision Medicine
1
2019
462
0.110
Why?
Humans
20
2025
146342
0.110
Why?
Reproducibility of Results
4
2019
3416
0.100
Why?
Aged
8
2024
26432
0.100
Why?
Ultrasonography, Interventional
1
2016
163
0.100
Why?
Alphapapillomavirus
1
2014
35
0.100
Why?
Male
10
2025
73396
0.100
Why?
Endosonography
2
2016
160
0.100
Why?
Female
12
2025
79499
0.100
Why?
Head and Neck Neoplasms
1
2018
563
0.090
Why?
Spinal Cord
1
2016
378
0.090
Why?
ErbB Receptors
2
2016
636
0.090
Why?
Sensitivity and Specificity
2
2024
1998
0.090
Why?
Neoplasms
2
2019
2954
0.090
Why?
Glioblastoma
1
2016
350
0.090
Why?
Gene Expression Profiling
1
2019
1792
0.090
Why?
CD5 Antigens
1
2011
10
0.080
Why?
Immunoglobulin kappa-Chains
1
2011
22
0.080
Why?
ADP-ribosyl Cyclase 1
1
2011
43
0.080
Why?
Receptors, IgE
1
2011
43
0.080
Why?
Adult
8
2024
41087
0.080
Why?
CD3 Complex
1
2011
113
0.080
Why?
Papillomavirus Infections
1
2014
345
0.080
Why?
Immunophenotyping
1
2011
324
0.070
Why?
Lung Diseases
1
2016
787
0.070
Why?
Prospective Studies
2
2019
8123
0.070
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2018
1998
0.070
Why?
Flow Cytometry
1
2011
1163
0.060
Why?
Kidney Diseases, Cystic
1
2006
24
0.060
Why?
Cyclic AMP-Dependent Protein Kinase RIalpha Subunit
1
2025
2
0.060
Why?
Hyphae
1
2024
11
0.050
Why?
Diaphyses
1
2023
10
0.050
Why?
Ulna
1
2023
35
0.050
Why?
Fungi
1
2024
120
0.050
Why?
Fibula
1
2023
37
0.050
Why?
Neoplasm Staging
2
2018
1488
0.050
Why?
Prognosis
2
2024
4351
0.050
Why?
Wound Healing
1
2024
354
0.040
Why?
Preoperative Care
1
2024
396
0.040
Why?
Fatal Outcome
1
2021
302
0.040
Why?
Adrenal Gland Neoplasms
1
2021
99
0.040
Why?
Lung Diseases, Interstitial
1
2006
677
0.040
Why?
Pre-Analytical Phase
1
2019
1
0.040
Why?
Ultrasonography
1
2024
788
0.040
Why?
Tumor Cells, Cultured
1
2021
882
0.040
Why?
United States
4
2019
16136
0.040
Why?
Singapore
1
2019
27
0.040
Why?
Wnt Signaling Pathway
1
2021
211
0.040
Why?
Retrospective Studies
3
2024
17438
0.040
Why?
Accreditation
1
2019
100
0.040
Why?
Radiotherapy, Image-Guided
1
2018
40
0.030
Why?
Cetuximab
1
2018
110
0.030
Why?
Phthalazines
1
2018
64
0.030
Why?
DNA Mutational Analysis
1
2018
410
0.030
Why?
Adolescent
3
2025
22557
0.030
Why?
Treatment Outcome
2
2024
11821
0.030
Why?
Thyroid Gland
1
2017
93
0.030
Why?
X-linked Nuclear Protein
1
2016
9
0.030
Why?
Neoplasm Grading
1
2017
313
0.030
Why?
Piperazines
1
2018
368
0.030
Why?
Neoplasm Metastasis
1
2018
693
0.030
Why?
Combined Modality Therapy
1
2018
1271
0.030
Why?
Societies, Medical
1
2019
907
0.030
Why?
PTEN Phosphohydrolase
1
2016
166
0.030
Why?
Risk Assessment
1
2024
3712
0.030
Why?
DNA Helicases
1
2016
138
0.030
Why?
Breast Neoplasms
1
2007
2418
0.030
Why?
Papanicolaou Test
1
2014
35
0.030
Why?
Vaginal Smears
1
2014
54
0.030
Why?
Cell Proliferation
1
2021
2502
0.020
Why?
Predictive Value of Tests
1
2019
2113
0.020
Why?
Biomedical Research
1
2019
729
0.020
Why?
Apoptosis
1
2021
2439
0.020
Why?
Risk
1
2014
920
0.020
Why?
Child
2
2025
22693
0.020
Why?
Uterine Cervical Neoplasms
1
2014
269
0.020
Why?
Nuclear Proteins
1
2016
740
0.020
Why?
Histones
1
2016
670
0.020
Why?
Child, Preschool
1
2025
11913
0.020
Why?
Membrane Proteins
1
2016
1130
0.020
Why?
Mastectomy, Modified Radical
1
2007
6
0.020
Why?
Selective Estrogen Receptor Modulators
1
2007
33
0.020
Why?
Carcinoma, Intraductal, Noninfiltrating
1
2007
61
0.020
Why?
Radiotherapy, Adjuvant
1
2007
222
0.020
Why?
Tamoxifen
1
2007
193
0.010
Why?
Magnetic Resonance Imaging
1
2016
3926
0.010
Why?
Surveys and Questionnaires
1
2016
6073
0.010
Why?
Lung
1
2016
4122
0.010
Why?
Young Adult
1
2019
14330
0.010
Why?
Marshall's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)